#42 BTC CompanyUnited States · NYSE American: APUS · Biotechnology
Apimeds Pharmaceuticals US
Apimeds Pharmaceuticals US is a clinical-stage biopharmaceutical company that got BTC in its December 2025 merger with MindWave Innovations and holds BTC as its primary reserve asset for a Digital Asset Treasury platform.
Treasury CompanyReport an error
BTC Holdings
1,004.84 BTC
As of 2026-06-30
- Holdings
BTC Reserve
1,004.84 BTC
Average Cost $90,682 / BTC
- Holdings
- Average Cost
- Purchase (size = amount)
- Sale (size = amount)
BTC history
| Date | Type | Change | Holdings | Cumulative cost | Average Cost | Sources | |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | Holdings Snapshot | +4.84 BTC+0.48% | 1,004.84 | $91.12M | $90,682 | Report | |
| 2026-03-31 | Holdings Snapshot | 0 BTC0% | 1,000 | $90.84M | $90,838 | Report | |
| 2025-12-31 | Holdings Snapshot | — | 1,000 | $90.84M | $90,838 | Report |
BTC holdings comparison
- #1Strategy847,666 BTC
- #2Twenty One Capital43,514 BTC
- #3Metaplanet43,000 BTC
- #4MARA Holdings35,577 BTC
- #5Strive27,462 BTC
- #6Galaxy Digital21,084 BTC
- #7Bullish19,990 BTC
- #8SpaceX18,712 BTC
- #9Hut 817,316 BTC
- #10Coinbase Global17,311 BTC
- #42Apimeds Pharmaceuticals US1,004.84 BTC
Treasury Asset prices: Powered by CoinGecko